For a patient with near occlusion of the internal carotid artery, should dual antiplatelet therapy be used instead of a direct‑acting oral anticoagulant (DOAC) plus aspirin?

Dual Antiplatelet Therapy is Preferred Over DOAC Plus Aspirin for Near Occlusion of the Internal Carotid Artery

For patients with near occlusion of the internal carotid artery, dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel is the recommended treatment approach, not DOAC plus aspirin. This recommendation is based on established guidelines for extracranial carotid atherosclerosis and the lack of evidence supporting anticoagulation in this specific anatomical scenario.

Rationale Based on Guidelines

The 2011 ASA/ACCF/AHA guidelines for extracranial carotid and vertebral artery disease provide clear direction 1, 2, 3, 4:

Antiplatelet agents are explicitly recommended over oral anticoagulation for patients with atherosclerosis of the extracranial carotid arteries, both with and without ischemic symptoms 1, 2. The guidelines state that for patients with obstructive or non-obstructive extracranial carotid atherosclerosis who have sustained ischemic stroke or TIA, antiplatelet therapy options include:

• Aspirin alone (75-325 mg daily)
• Clopidogrel alone (75 mg daily)
• Aspirin plus extended-release dipyridamole (25/200 mg twice daily)

These regimens are preferred over the combination of aspirin with clopidogrel for long-term management 1, 2.

Why Not Anticoagulation?

The evidence consistently shows that anticoagulation provides no benefit over antiplatelet therapy for carotid atherosclerosis 1, 2. The WARSS trial specifically examined patients with severe large-artery stenosis or occlusion and found no benefit of warfarin over aspirin after 2 years 4.

More recent evidence from the 2024 ESC guidelines reinforces that adding antiplatelet treatment to anticoagulation is not recommended in patients with atrial fibrillation to prevent recurrent embolic stroke 5. The combination increases bleeding risk without proven efficacy benefit.

Special Considerations for Near Occlusion

Near occlusion of the internal carotid artery represents a specific high-risk anatomical variant. Recent research suggests:

• Endovascular treatment for near-occlusion has a 100% technical success rate with dual antiplatelet therapy 6
• The pooled stroke rate with best medical treatment (which includes antiplatelet therapy) is 8.39%, compared to 1.52% after carotid endarterectomy 7
• Patients should receive DAPT with aspirin (81-325 mg) plus clopidogrel (75 mg) for at least 30 days before and after any carotid intervention 3

When DOACs Enter the Picture

DOACs should only be used in patients with near-occlusion of the carotid artery if there is a separate, compelling indication for anticoagulation (such as atrial fibrillation or mechanical heart valve) 1, 2. In these cases:

• The DOAC alone is preferred over DOAC plus antiplatelet therapy for long-term management 5
• If recent carotid stenting occurred (within 1-3 months), stop aspirin, continue clopidogrel, and add the DOAC 8
• After the standard DAPT period ends, transition to DOAC monotherapy 8

Recent data from 2026 shows that DOAC plus single antiplatelet therapy may be feasible for carotid stenting in patients with atrial fibrillation, avoiding triple therapy and its bleeding risks 9, 10. However, there are concerns about increased in-stent stenosis with DOACs, particularly when combined with single antiplatelet therapy 11.

Critical Pitfalls to Avoid

1. Do not use DOACs for carotid atherosclerosis alone - there is no indication for anticoagulation unless a separate cardioembolic source exists
2. Avoid triple therapy (DOAC + aspirin + clopidogrel) - this dramatically increases bleeding risk without proven benefit 12, 8
3. Do not combine aspirin with clopidogrel within 3 months after stroke or TIA - this increases bleeding without additional benefit 3, 4
4. Never use full-intensity parenteral anticoagulation (heparin or LMWH) for acute ischemic stroke from carotid disease 3, 4

Practical Algorithm

For near-occlusion of internal carotid artery:

1. No atrial fibrillation or other anticoagulation indication:

   • Start aspirin 75-325 mg daily + clopidogrel 75 mg daily
   • Continue indefinitely unless intervention planned

2. With atrial fibrillation requiring anticoagulation:

   • If no recent intervention: DOAC monotherapy (not DOAC + aspirin)
   • If carotid stenting planned: Start aspirin + clopidogrel at least 2 weeks before procedure
   • Post-stenting (1-3 months): Stop aspirin, continue clopidogrel + DOAC
   • After 3 months: DOAC monotherapy

3. Consider revascularization (endarterectomy or stenting) given the high stroke risk with medical management alone, using the same antiplatelet protocols 3, 1